Revealed: Court battle over drug costing NHS £300m a year

By Henry Anderson2025-07-31T12:50:00

The UK’s leading pharmaceutical firm has said it will have to cancel projects aiming to help thousands of NHS patients if it loses a legal case that would bring cheaper alternatives on to the market.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters
Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
10 expert briefings every fortnight (Premium only)

to HSJ

Already a subscriber? Sign into your account here